Åke Borg
81 – 90 of 400
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant : Breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
- Contribution to journal › Article
-
Mark
Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication
- Contribution to journal › Article
-
Mark
Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative
- Contribution to journal › Article
-
Mark
Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility
- Contribution to journal › Article
-
Mark
Multidimensional transcriptomics provides detailed information about immune cell distribution an identity in HER2+ breast tumors
(2018) In BioRxiv
- Working paper/Preprint › Preprint in preprint archive
- 2017
-
Mark
Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing
- Contribution to journal › Article
-
Mark
Cytohesin 1 regulates homing and engraftment of human hematopoietic stem and progenitor cells
- Contribution to journal › Article
-
Mark
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
- Contribution to journal › Article
-
Mark
Abstract P1-07-17: The SCAN-B study: 5-year summary of a large-scale population-based prospective breast cancer translational genomics platform covering a wide geography of Sweden (NCT02306096)
- Contribution to journal › Published meeting abstract
-
Mark
Myoepithelium assessment with p63 immunostaining in formalinfixed paraffin-embedded breast cancer tissue pre-treated with RNA-later
- Contribution to journal › Published meeting abstract
